- COPAXONE®: A unique RRMS therapy thought to modify the immune response by helping to restore balance in the immune systema
the central nervous system (CNS).b,c
- Avonex® (interferon beta-1a)
- Betaseron® (interferon beta-1b)
- Extavia® (interferon beta-1b)
- Rebif® (interferon beta-1a)
- GilenyaTM (fingolimod): Believed to work by preventing immune cells from leaving the lymph nodes. As a result, immune cells in the CNS and the body are reducedd
- Tysabri® (natalizumab): Modifies the immune response by reducing the movement of immune cells into the CNSe
- Novantrone® (mitoxantrone): An immunosuppressant that is approved for use in patients with worsening RRMS, secondary-progressive MS, or progressive-relapsing MS
Approved therapies at a glance
Click here for an overview of all approved RRMS therapies.
Remember that these disease-modifying therapies don’t treat symptoms of MS. You and your doctor can work together on strategies to deal with symptoms. You can also get tips from others with MS who have gone through what you’re experiencing.
References:
a. COPAXONE® (glatiramer acetate injection) prescribing information. Teva Neuroscience, Inc. b. Bennett JL, Stüve O. Clin Neuropharmacol. 2009;32(3):121-132. c. Betaseron® (interferon beta-1b) prescribing information. Bayer HealthCare Pharmaceuticals Inc. d. Gilenya™ (fingolimod) prescribing information. Novartis Pharmaceuticals Corportation. e. Tysabri® (natalizumab) prescribing information. Biogen Idec Inc